Skip to content
Everyone in the U.S. over age 60 should get a second booster shot of their COVID-19 vaccine, Dr. Ashish K. Jha, a White House […]
White House COVID advisor recommends a second booster for those over 60 Read More »
According to a new study from the Centers for Disease Control and Prevention (CDC), cases of several types of sexually transmitted diseases increased in
CDC: Pandemic didn’t slow the spread of STDs Read More »
House Ways and Means Committee Republicans reintroduced several tax bills that would provide critical drug R&D tax credits, particularly for small biotechs and startups.
Ways & Means Republicans reintroduce drug R&D tax credits Read More »
The U.S. Food and Drug Administration (FDA) approved Kite’s new CAR T-cell therapy manufacturing facility in Frederick, Maryland, the company announced. Kite, a Gilead
FDA approves Kite’s CAR T-cell therapy manufacturing facility in Maryland Read More »
Too many doctors prescribed antibiotics for COVID-19, the Centers for Disease Control (CDC) reported earlier this month, even though these medications could not fight
Too many doctors prescribed antibiotics for COVID-19, says CDC Read More »
In an article in the International Business Times, BIO President and CEO Dr. Michelle McMurry-Heath outlines the problems with a proposed international IP waiver
BIO’s View: How to really close the global vaccine gap Read More »
As we get ready for World Immunization Week, we celebrate the rapid and successful development of COVID-19 vaccines—but are also reminded of the difficulties
World Immunization Week: What you need to know Read More »
The U.S. Food and Drug Administration (FDA) announced Thursday that it has granted emergency use authorization for the first breath test for COVID-19, the
FDA gives emergency use authorization for a COVID-19 breath test Read More »
A booster shot of the Pfizer-BioNTech vaccine appeared to increase the immune response against coronavirus in children aged 5 through 11, providing significant protection
Pfizer says booster helps 5-11-year-olds, will request FDA approval Read More »
This month’s decision by the U.S. Centers for Medicare & Medicaid Services (CMS) to limit coverage of the Alzheimer’s drug Aduhelm to patients enrolled in
Aduhelm decision will ‘chill’ innovation, say BIO experts Read More »
